Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and Peripheral Artery Disease: Insights From the ARISTOTLE Trial

Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and Peripheral Artery Disease: Insights From the ARISTOTLE Trial

BackgroundWe studied (1) the rates of stroke or systemic embolism and bleeding in patients with atrial fibrillation and peripheral artery disease (PAD) and (2) the efficacy and safety of apixaban versus warfarin in patients with atrial fibrillation with and without PAD. Methods and ResultsThe Apixab...

Full description

Bibliographic Details
Main Authors: Peter T. Hu, Renato D. Lopes, Susanna R. Stevens, Lars Wallentin, Laine Thomas, John H. Alexander, Michael Hanna, Basil S. Lewis, Freek W. A. Verheugt, Christopher B. Granger, W. Schuyler Jones
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
apixaban
atrial fibrillation
bleeding
peripheral artery disease
stroke
systemic embolism
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.116.004699

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.116.004699

Similar Items